1. Home
  2. CDTX vs GSL Comparison

CDTX vs GSL Comparison

Compare CDTX & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • GSL
  • Stock Information
  • Founded
  • CDTX 2012
  • GSL 2007
  • Country
  • CDTX United States
  • GSL Greece
  • Employees
  • CDTX N/A
  • GSL N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • GSL Marine Transportation
  • Sector
  • CDTX Health Care
  • GSL Consumer Discretionary
  • Exchange
  • CDTX Nasdaq
  • GSL Nasdaq
  • Market Cap
  • CDTX 980.1M
  • GSL 972.2M
  • IPO Year
  • CDTX 2015
  • GSL 2006
  • Fundamental
  • Price
  • CDTX $63.31
  • GSL $28.50
  • Analyst Decision
  • CDTX Strong Buy
  • GSL Strong Buy
  • Analyst Count
  • CDTX 11
  • GSL 1
  • Target Price
  • CDTX $52.11
  • GSL $30.00
  • AVG Volume (30 Days)
  • CDTX 659.9K
  • GSL 305.6K
  • Earning Date
  • CDTX 08-07-2025
  • GSL 08-05-2025
  • Dividend Yield
  • CDTX N/A
  • GSL 7.36%
  • EPS Growth
  • CDTX N/A
  • GSL 20.64
  • EPS
  • CDTX N/A
  • GSL 10.54
  • Revenue
  • CDTX $302,000.00
  • GSL $715,232,000.00
  • Revenue This Year
  • CDTX N/A
  • GSL $4.15
  • Revenue Next Year
  • CDTX N/A
  • GSL N/A
  • P/E Ratio
  • CDTX N/A
  • GSL $2.71
  • Revenue Growth
  • CDTX N/A
  • GSL 3.83
  • 52 Week Low
  • CDTX $10.14
  • GSL $17.73
  • 52 Week High
  • CDTX $66.95
  • GSL $29.23
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 70.66
  • GSL 60.86
  • Support Level
  • CDTX $60.71
  • GSL $27.57
  • Resistance Level
  • CDTX $66.95
  • GSL $29.17
  • Average True Range (ATR)
  • CDTX 4.25
  • GSL 0.48
  • MACD
  • CDTX -0.39
  • GSL -0.02
  • Stochastic Oscillator
  • CDTX 79.25
  • GSL 64.04

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About GSL Global Ship Lease Inc New

Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.

Share on Social Networks: